Dapagliflozin does not show improvement in glycemic control in moderate renal impairment: a question of analytical rigor?
- 1 December 2014
- journal article
- Published by Elsevier in Kidney International
- Vol. 86 (6) , 1271-1272
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic controlKidney International, 2014
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013